Skip to main content

Advertisement

SpringerLink
Log in

Hypertension

The Framingham risk score is valuable in Europeans

  • News & Views
  • Published:

From Nature Reviews Nephrology

View current issue Sign up to alerts

The Framingham hypertension risk score developed in the US has been validated in a large group of London-based civil servants. The score is therefore a useful tool for estimating the short-term risk of developing hypertension in a European population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ezzati, M., Lopez, A. D., Rodgers, A., Vander Hoorn, S. & Murray, C. J. Selected major risk factors and global and regional burden of disease. Lancet 360, 1347–1360 (2002).

    Article  Google Scholar 

  2. Lawes, C. M., Vander Hoorn, S. & Rodgers, A. Global burden of blood-pressure-related disease, 2001. Lancet 371, 1513–1518 (2008).

    Article  Google Scholar 

  3. Vasan, R. S., Larson, M. G., Leip, E. P., Kannel, W. B. & Levy, D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 358, 1682–1686 (2001).

    Article  CAS  Google Scholar 

  4. Chobanian, A. V. et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42, 1206–1252 (2003).

    Article  CAS  Google Scholar 

  5. Parikh, N. I. et al. A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann. Intern. Med. 148, 102–110 (2008).

    Article  Google Scholar 

  6. Kivimäki, M. et al. Validating the Framingham Hypertension Risk Score: results from the Whitehall II study. Hypertension 54, 496–501 (2009).

    Article  Google Scholar 

  7. Ruilope, L. et al. The kidney and cardiovascular risk--implications for management: a consensus statement from the European Society of Hypertension. Blood Press. 16, 72–79 (2007).

    Article  Google Scholar 

  8. He, J., Whelton, P. K., Appel, L. J., Charleston, J. & Klag, M. J. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 35, 544–549 (2000).

    Article  CAS  Google Scholar 

  9. Julius, S. et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N. Engl. J. Med. 354, 1685–1697 (2006).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unidad de Hipertensión, Hospital 12 de Octubre, Avenida Cordoba s/n, 28041, Madrid, Spain

    Luis M. Ruilope

Authors
  1. Luis M. Ruilope
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruilope, L. The Framingham risk score is valuable in Europeans. Nat Rev Nephrol 6, 14–15 (2010). https://doi.org/10.1038/nrneph.2009.205

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2009.205

  • Springer Nature Limited

This article is cited by

Search

Navigation